Adrenomedullin treatment reduces intestinal inflammation and maintains epithelial barrier function in mice administered dextran sulphate sodium

Microbiology and Immunology

Volumn 53, Issue 10, 2009, Pages 573-581

  Ashizuka, Shinya ^a   Inagaki Ohara, Kyoko ^b,c   Kuwasako, Kenji ^a   Kato, Johji ^a   Inatsu, Haruhiko ^a   Kitamura, Kazuo ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Adrenomedullin; Colitis; Epithelial barrier

Indexed keywords

ADRENOMEDULLIN; CYTOKINE; DEXTRAN SULFATE; GAMMA INTERFERON; STAT1 PROTEIN; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; CELL ADHESION MOLECULE; STAT1 PROTEIN, MOUSE; STAT3 PROTEIN, MOUSE; VASODILATOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL JUNCTION; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; DRUG MECHANISM; INTESTINE EPITHELIUM; MALE; MOUSE; NONHUMAN; PERMEABILITY; PROTEIN PHOSPHORYLATION; T LYMPHOCYTE; TIGHT JUNCTION; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT REDUCTION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENTERITIS; HUMAN; INFLAMMATION; INTESTINE MUCOSA; METABOLISM; PATHOPHYSIOLOGY; RECTAL DRUG ADMINISTRATION;

MUS;

ADMINISTRATION, RECTAL; ADRENOMEDULLIN; ANIMALS; CELL ADHESION MOLECULES; CYTOKINES; DEXTRAN SULFATE; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; VASODILATOR AGENTS;

EID: 73349093417     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2009.00159.x     Document Type: Article

References (51)

1. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., Eto T. (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192: 553-60.
2. Kitani M., Sakata J., Asada Y., Kitamura K., Eto T. (1998) Distribution and expression of adrenomedullin in human gastrointestinal tissue. Ann Clin Biochem35(Pt 5): 643-8.
3. Asada Y., Hara S., Marutsuka K., Kitamura K., Tsuji T., Sakata J., Sato Y., Kisanuki A., Eto T., Sumiyoshi A. (1999) Novel distribution of adrenomedullin-immunoreactive cells in human tissues. Histochem Cell Biol 112: 185-91.
4. Martinez A., Miller M.J., Unsworth E.J., Siegfried J.M., Cuttitta F. (1995) Expression of adrenomedullin in normal human lung and in pulmonary tumors. Endocrinology 136: 4099-105.
5. Cameron V.A., Fleming A.M. (1998) Novel sites of adrenomedullin gene expression in mouse and rat tissues. Endocrinology 139: 2253-64.
6. Elsasser T.H., Kahl S. (2002) Adrenomedullin has multiple roles in disease stress: development and remission of the inflammatory response. Microsc Res Tech 57: 120-9.
7. Marutsuka K., Nawa Y., Asada Y., Hara S., Kitamura K., Eto T., Sumiyoshi A. (2001) Adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP) are present in human colonic epithelia and exert an antimicrobial effect. Exp Physiol 86: 543-5.
8. Ueda S., Nishio K., Minamino N., Kubo A., Akai Y., Kangawa K., Matsuo H., Fujimura Y., Yoshioka A., Masui K., Doi N., Murao Y., Miyamoto S. (1999) Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. Am J Respir Crit Care Med 160: 132-6.
9. Fiocchi C. (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182-205.
10. Blumberg R.S., Saubermann L.J., StroberW. (1999) Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr Opin Immunol 11: 648-56.
11. Gassler N., Rohr C., Schneider A., Kartenbeck J., Bach A., Obermuller N., Otto H.F., Autschbach F. (2001) Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol 281: G216-28.
12. Bouma G., StroberW. (2003) The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3: 521-33.
13. Cummings J.H., Macfarlane G.T., Macfarlane S. (2003) Intestinal bacteria and ulcerative colitis. Curr Issues Intest Microbiol 4: 9-20.
14. Inagaki-Ohara K., Sasaki A., Matsuzaki G., Ikeda T., Hotokezaka M., Chijiiwa K., Kubo M., Yoshida H., Nawa Y., Yoshimura A. (2006) Suppressor of cytokine signalling 1 in lymphocytes regulates the development of intestinal inflammation in mice. Gut 55: 212-9.
15. Yamamoto M., Fujihashi K., Kawabata K., McGhee J.R., Kiyono H. (1998) A mucosal intranet: intestinal epithelial cells down-regulate intraepithelial, but not peripheral, T lymphocytes. J Immunol 160: 2188-96.
16. Inagaki-Ohara K., Chinen T., Matsuzaki G., Sasaki A., Sakamoto Y., Hiromatsu K., Nakamura-Uchiyama F., Nawa Y., Yoshimura A. (2004) Mucosal T cells bearing TCRgammadelta play a protective role in intestinal inflammation. J Immunol 173: 1390-8.
17. Cheroutre H. (2005) IELs: enforcing law and order in the court of the intestinal epithelium. Immunol Rev 206: 114-31.
18. Komori H.K., Meehan T.F., HavranW.L. (2006) Epithelial and mucosal gamma delta T cells. Curr Opin Immunol 18: 534-8.
19. Inagaki-Ohara K., Dewi F.N., Hisaeda H., Smith A.L., Jimi F., Miyahira M., Abdel-Aleem A.S., Horii Y., Nawa Y. (2006) Intestinal intraepithelial lymphocytes sustain the epithelial barrier function against Eimeria vermiformis infection. Infect Immun 74: 5292-301.
20. Ashizuka S., Ishikawa N., Kato J., Yamaga J., Inatsu H., Eto T., Kitamura K. (2005) Effect of adrenomedullin administration on acetic acid-induced colitis in rats. Peptides 26: 2610-5.
21. Gonzalez-Rey E., Fernandez-Martin A., Chorny A., Delgado M. (2006) Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease. Gut 55: 824-32.
22. Sugimoto K., Ogawa A., Mizoguchi E., Shimomura Y., Andoh A., Bhan A.K., Blumberg R.S., Xavier R.J., Mizoguchi A. (2008) IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 118: 534-44.
23. Inagaki-Ohara K., Sawaguchi A., Suganuma T., Matsuzaki G., Nawa Y. (2005) Intraepithelial lymphocytes express junctional molecules in murine small intestine. Biochem Biophys Res Commun 331: 977-83.
24. Allaker R.P., Grosvenor P.W., McAnerney D.C., Sheehan B.E., Srikanta B.H., Pell K., Kapas S. (2006) Mechanisms of adrenomedullin antimicrobial action. Peptides 27: 661-6.
25. Fuss I.J., Neurath M., Boirivant M., Klein J.S., de la Motte C., Strong S.A., Fiocchi C., StroberW. (1996) Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 157: 1261-70.
26. Podolsky D.K. (1991) Inflammatory bowel disease (1).N Engl J Med 325: 928-37.
27. Rogler G., Andus T. (1998) Cytokines in inflammatory bowel disease. World J Surg 22: 382-9.
28. LeonardW.J., O'Shea J.J. (1998) Jaks and STATs: biological implications. Annu Rev Immunol 16: 293-322.
29. Atreya R., Neurath M.F. (2008) Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. Curr Drug Targets 9: 369-74.
30. Schreiber S., Rosenstiel P., Hampe J., Nikolaus S., Groessner B., Schottelius A., Kuhbacher T., Hamling J., Folsch U.R., Seegert D. (2002) Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut 51: 379-85.
31. Inagaki-Ohara K., Hanada T., Yoshimura A. (2003) Negative regulation of cytokine signaling and inflammatory diseases. Curr Opin Pharmacol 3: 435-42.
32. Mombaerts P., Mizoguchi E., Grusby M.J., Glimcher L.H., Bhan A.K., Tonegawa S. (1993) Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75: 274-82.
33. Chen Y., Chou K., Fuchs E., HavranW.L., Boismenu R. (2002) Protection of the intestinal mucosa by intraepithelial gamma delta T cells. Proc Natl Acad Sci U S A 99: 14338-43.
34. Berkes J., Viswanathan V.K., Savkovic S.D., Hecht G. (2003) Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 52: 439-51.
35. Schneeberger E.E., Lynch R.D. (2004) The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 286: C1213-28.
36. Axelsson L.G., Landstrom E., Goldschmidt T.J., Gronberg A., Bylund-Fellenius A.C. (1996) Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: effects in CD4(+) -cell depleted, athymic and NK-cell depleted SCID mice. Inflamm Res 45: 181-91.
37. Dieleman L.A., Ridwan B.U., Tennyson G.S., Beagley K.W., Bucy R.P., Elson C.O. (1994) Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107: 1643-52.
38. Egger B., Bajaj-Elliott M., MacDonald T.T., Inglin R., Eysselein V.E., Buchler M.W. (2000) Characterisation of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion 62: 240-8.
39. Powrie F., Carlino J., Leach M.W., Mauze S., Coffman R.L. (1996) A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J ExpMed 183: 2669-74.
40. Neurath M.F., Fuss I., Kelsall B.L., Presky D.H.,WaegellW., Strober W. (1996) Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J ExpMed 183: 2605-16.
41. Kitani A., Fuss I.J., Nakamura K., Schwartz O.M., Usui T., Strober W. (2000) Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation. J ExpMed 192: 41-52.
42. Ehrhardt R.O., StroberW., Harriman G.R. (1992) Effect of transforming growth factor (TGF)-beta 1 on IgA isotype expression. TGF-beta 1 induces a small increase in sIgA+ B cells regardless of the method of B cell activation. J Immunol 148: 3830-6.
43. Fujihashi K., Kawabata S., Hiroi T., Yamamoto M., McGhee J.R., Nishikawa S., Kiyono H. (1996) Interleukin 2 (IL-2) and interleukin
44. (IL-7) reciprocally induce IL-7 and IL-2 receptors on gamma delta T-cell receptor-positive intraepithelial lymphocytes. Proc Natl Acad Sci U S A 93: 3613-8.
45. Inagaki-Ohara K., Nishimura H., Mitani A., Yoshikai Y. (1997) Interleukin-15 preferentially promotes the growth of intestinal intraepithelial lymphocytes bearing gamma delta T cell receptor in mice. Eur J Immunol 27: 2885-91.
46. Komano H., Fujiura Y., Kawaguchi M., Matsumoto S., Hashimoto Y., Obana S., Mombaerts P., Tonegawa S., Yamamoto H., Itohara S., et al. (1995) Homeostatic regulation of intestinal epithelia by intraepithelial gamma delta T cells. Proc Natl Acad Sci USA 92: 6147-51.
47. Campbell N., Yio X.Y., So L.P., Li Y., Mayer L. (1999) The intestinal epithelial cell: processing and presentation of antigen to the mucosal immune system. Immunol Rev 172: 315-24.
48. O'Neil D.A., Porter E.M., Elewaut D., Anderson G.M., Eckmann L., Ganz T., Kagnoff M.F. (1999) Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 163: 6718-24.
49. Mankertz J., Tavalali S., Schmitz H., Mankertz A., Riecken E.O., Fromm M., Schulzke J.D. (2000) Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J Cell Sci 113(Pt 11): 2085-90.
50. Teahon K., Smethurst P., Levi A.J., Menzies I.S., Bjarnason I. (1992) Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut 33: 320-3.
51. Irvine E.J., Marshall J.K. (2000) Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology 119: 1740-4.